-
1
-
-
40949121112
-
Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions
-
DOI 10.1097/JCP.0b013e318166c4f7, PII 0000471420080400000002
-
Birkenaes AB, Birkeland KI, Engh JA, et al. Dyslipidemia independent of body mass in antipsychotic-treated patients under real-life conditions. J Clin Psychopharmacol. 2008;28:132-137. (Pubitemid 351417117)
-
(2008)
Journal of Clinical Psychopharmacology
, vol.28
, Issue.2
, pp. 132-137
-
-
Birkenaes, A.B.1
Birkeland, K.I.2
Engh, J.A.3
Faerden, A.4
Jonsdottir, H.5
Ringen, P.A.6
Friis, S.7
Opjordsmoen, S.8
Andreassen, O.A.9
-
2
-
-
34247231457
-
Proposal for a new tool to evaluate drug interaction cases
-
DOI 10.1345/aph.1H423
-
Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674-680. (Pubitemid 46625492)
-
(2007)
Annals of Pharmacotherapy
, vol.41
, Issue.4
, pp. 674-680
-
-
Horn, J.R.1
Hansten, P.D.2
Chan, L.-N.3
-
3
-
-
33645219539
-
Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations
-
DOI 10.1097/01.yic.0000188213.46667.f1, PII 0000485020060300000002
-
Aichhorn W, Marksteiner J, Walch T, et al. Influence of age, gender, body weight and valproate comedication on quetiapine plasma concentrations. Int Clin Psychopharmacol. 2006;21:81-85. (Pubitemid 43740314)
-
(2006)
International Clinical Psychopharmacology
, vol.21
, Issue.2
, pp. 81-85
-
-
Aichhorn, W.1
Marksteiner, J.2
Walch, T.3
Zernig, G.4
Saria, A.5
Kemmler, G.6
-
4
-
-
67651216043
-
Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a veterans affairs population
-
Duncan EJ, Woolson SL, Hamer RM, et al. Risk of lipid abnormality with haloperidol, olanzapine, quetiapine, and risperidone in a veterans affairs population. Int Clin Psychopharmacol. 2009;24:204-213.
-
(2009)
Int Clin Psychopharmacol
, vol.24
, pp. 204-213
-
-
Duncan, E.J.1
Woolson, S.L.2
Hamer, R.M.3
-
5
-
-
34147150577
-
A clinical study of the association of antipsychotics with hyperlipidemia
-
DOI 10.1016/j.schres.2007.01.015, PII S0920996407000679
-
de Leon J, Susce MT, Johnson M, et al. A clinical study of the association of antipsychotics with hyperlipidemia. Schizophr Res. 2007;92:95-102. (Pubitemid 46561228)
-
(2007)
Schizophrenia Research
, vol.92
, Issue.1-3
, pp. 95-102
-
-
De Leon, J.1
Susce, M.T.2
Johnson, M.3
Hardin, M.4
Pointer, L.5
Ruano, G.6
Windemuth, A.7
Diaz, F.J.8
-
6
-
-
1942534724
-
The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy
-
Nikolaos T, Stylianos G, Chryssoula N, et al. The effect of long-term antiepileptic treatment on serum cholesterol (TC, HDL, LDL) and triglyceride levels in adult epileptic patients on monotherapy. Med Sci Monit. 2004;10:MT50-MT52. (Pubitemid 38525090)
-
(2004)
Medical Science Monitor
, vol.10
, Issue.4
-
-
Nikolaos, T.1
Stylianos, G.2
Chryssoula, N.3
Irini, P.4
Christos, M.5
Dimitrios, T.6
Konstantinos, P.7
Antonis, T.8
-
7
-
-
0343526753
-
The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy
-
DOI 10.1016/S0920-1211(00)00119-4, PII S0920121100001194
-
Eiris J, Novo-Rodriguez MI, Del Rio M, et al. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy. Epilepsy Res. 2000;41:1-7. (Pubitemid 30621396)
-
(2000)
Epilepsy Research
, vol.41
, Issue.1
, pp. 1-7
-
-
Eiris, J.1
Novo-Rodriguez, M.I.2
Del Rio, M.3
Meseguer, P.4
Del Rio, M.C.5
Castro-Gago, M.6
-
8
-
-
58549114676
-
Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy
-
Grosso S, Mostardini R, Piccini B, et al. Body mass index and serum lipid changes during treatment with valproic acid in children with epilepsy. Ann Pharmacother. 2009;43:45-50.
-
(2009)
Ann Pharmacother
, vol.43
, pp. 45-50
-
-
Grosso, S.1
Mostardini, R.2
Piccini, B.3
-
9
-
-
34447498647
-
Cervical dystonia due to interaction of valproic acid and quetiapine [4]
-
DOI 10.1097/01.jcp.0000264989.63227.82, PII 0000471420070800000015
-
Habermeyer B, Rabovsky K, Jentzsch C, et al. Cervical dystonia due to interaction of valproic acid and quetiapine. J Clin Psychopharmacol. 2007;27:396-397. (Pubitemid 47075514)
-
(2007)
Journal of Clinical Psychopharmacology
, vol.27
, Issue.4
, pp. 396-397
-
-
Habermeyer, B.1
Rabovsky, K.2
Jentzsch, C.3
Pinard, K.4
Muller-Spahn, F.5
-
10
-
-
0036468699
-
Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin
-
DOI 10.1016/S0006-3223(01)01333-6, PII S0006322301013336
-
Furst BA, Champion KM, Pierre JM, et al. Possible association of QTc interval prolongation with co-administration of quetiapine and lovastatin. Biol Psychiatry. 2002;51:264-265. (Pubitemid 34142639)
-
(2002)
Biological Psychiatry
, vol.51
, Issue.3
, pp. 264-265
-
-
Furst, B.A.1
Champion, K.M.2
Pierre, J.M.3
Wirshing, D.A.4
Wirshing, W.C.5
-
11
-
-
34548446317
-
New onset diabetes with ketoacidosis attributed to quetiapine
-
DOI 10.1097/SMJ.0b013e31804b1e4d, PII 0000761120070800000015
-
Marlowe KF, Howard D, Chung A. Newonset diabetes with ketoacidosis attributed to quetiapine. South Med J. 2007;100:829-831. (Pubitemid 47356885)
-
(2007)
Southern Medical Journal
, vol.100
, Issue.8
, pp. 829-831
-
-
Marlowe, K.F.1
Howard, D.2
Chung, A.3
|